Form 4 holding
Director
Latigo Biotherapeutics, Inc.
- Security class
- Director Stock Option (right to buy)
- Shares / value
- 105,542
- Estimated value
- Report date
- 06 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount